Novartis AG
NOVN.SW News Today: Stay Updated with the Latest Novartis AG News in Real Time
Find NOVN.SW news now at Meyka AI. Stay informed with the latest Novartis AG stocks updates, including price news, market analysis, and expert insights.
Biogen to Buy Apellis in $5.6 Billion All‑Cash Deal
Biotech giant Biogen announced a major deal to acquire Apellis Pharmaceuticals for $5.6 billion in cash, marking one of the largest strategic transactions in the sector this year. The acquisition is aimed at strengthening Biogen’s drug pipeline, especially in areas such as eye disease and immunology where Apellis has developed promising therapies. Investors reacted strongly…
Eli Lilly Expands AI Drug Discovery Deal with Insilico Medicine
The pharmaceutical industry is changing fast. And at the center of this shift is Eli Lilly. In March 2026, Eli Lilly expanded its partnership with Insilico Medicine. The deal could reach $2.75 billion, making it one of the biggest AI-driven drug discovery agreements so far. We from the healthcare and tech space view this as…
Novartis to Acquire U.S. Biotech Firm Excellergy in Deal Worth Up to $2 Billion
Swiss pharmaceutical giant Novartis announced plans to acquire the U.S. biotech company Excellergy in a major strategic deal valued at up to $2 billion. The acquisition aims to expand Novartis’s drug development pipeline and strengthen its position in innovative therapies. Market watchers believe the transaction could have significant effects on the broader stock market and…
Novartis AG (NOVN.SW, SIX) closes CHF117.48 on 24 Mar 2026: 3.25M shares most active
NOVN.SW stock closed CHF117.48 on 24 Mar 2026 with 3.25M volume; read short-term outlook and Meyka AI forecast
NOVN.SW Novartis AG (SIX) drops 4.02% on 19 Mar 2026: volume surge may offer tactical entry
NOVN.SW stock drops to CHF116.88 with heavy volume; analysis, grade and Meyka AI forecast for investors
MOLN.SW Molecular Partners AG (SIX) -1.20% to CHF3.28 on 18 Mar 2026: CHF3.15 key
Intraday: MOLN.SW stock down 1.20% to CHF3.28 on SIX; CHF3.15 support and Meyka AI forecast included
Novartis AG NOVN.SW CHF121.96 intraday SIX 17 Mar 2026: watch Avidity funding
Intraday NOVN.SW stock update: CHF121.96 on SIX with 1.18M volume; Avidity funding and forecasts reviewed
BAYN.SW Bayer AG (SIX) up 10.32% pre-market 17 Mar 2026: check key drivers
Pre-market BAYN.SW stock jumps 10.32% to CHF36.13; analysis, grade and Meyka AI forecast included
MOLN.SW down 11.14% pre-market Mar 2026: Molecular Partners CHF3.35 (SIX): view
MOLN.SW stock slides 11.14% pre-market to CHF3.35 on SIX; analyst grade, forecasts and catalyst-driven risks